We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+13.4%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$10.9B
AUM Growth
+$1.67B
(+18%)
Cap. Flow
+$806M
Cap. Flow
% of AUM
7.42%
Top 10 Holdings %
Top 10 Hldgs %
14.27%
Holding
678
New
211
Increased
171
Reduced
126
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ERF
Enerplus Corporation
ERF
|
+$91.2M |
| 2 |
TE Connectivity
TEL
|
+$81.6M |
| 3 |
Palo Alto Networks
PANW
|
+$78.9M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$75.6M |
| 5 |
Honeywell
HON
|
+$70.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$113M |
| 2 |
AbbVie
ABBV
|
+$110M |
| 3 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
+$88.1M |
| 4 |
SPLK
Splunk Inc
SPLK
|
+$70.1M |
| 5 |
Synopsys
SNPS
|
+$64.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.5% |
| 2 | Technology | 22.75% |
| 3 | Industrials | 9.82% |
| 4 | Energy | 8.34% |
| 5 | Consumer Discretionary | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Everest Group
EG
$14.2B
| $22.4M | 0.21% |
+56,452
| New | +$21.2M |
|
152
Arista Networks
ANET
$240B
| $22.3M | 0.21% |
+307,816
| New | +$20.8M |
|
153
Zebra Technologies
ZBRA
$17.6B
| $22.1M | 0.2% |
+73,308
| New | +$19.6M |
|
154
VeriSign
VRSN
$27B
| $22M | 0.2% |
116,257
-26,942
| -19% | -$5.29M |
|
155
Iovance Biotherapeutics
IOVA
$1.95B
| $22M | 0.2% |
1,482,859
-121,847
| -8% | -$1.42M |
|
156
Dutch Bros
BROS
$8.8B
| $22M | 0.2% |
665,908
+555,126
| +501% | +$16.4M |
|
157
Watsco Inc
WSO
$13.8B
| $21.9M | 0.2% |
50,779
+35,882
| +241% | +$14.4M |
|
158
On Holding
ONON
$12.5B
| $21.9M | 0.2% |
618,548
+183
| +0% | +$5.59K |
|
159
BridgeBio Pharma
BBIO
$16.1B
| $21.7M | 0.2% |
700,749
+410,749
| +142% | +$14M |
|
160
Applied Materials
AMAT
$434B
| $21.6M | 0.2% |
+104,802
| New | +$19.2M |
|
161
Pegasystems
PEGA
$5.22B
| $21.5M | 0.2% |
666,708
-164,244
| -20% | -$4.61M |
|
162
TG Therapeutics
TGTX
$7.46B
| $21.4M | 0.2% |
1,404,597
-363,837
| -21% | -$5.8M |
|
|
ESPR
163
DELISTED
Esperion Therapeutics
ESPR
| $21.2M | 0.2% |
7,922,229
+7,631,847
| +2,628% | +$18.5M |
|
164
SharkNinja
SN
$23.8B
| $21M | 0.19% |
337,717
+31,416
| +10% | +$1.66M |
|
165
Pultegroup
PHM
$25.1B
| $20.8M | 0.19% |
+172,359
| New | +$18.5M |
|
166
TD Synnex
SNX
$21.1B
| $20.5M | 0.19% |
181,139
-129,989
| -42% | -$13.5M |
|
167
lululemon athletica
LULU
$14B
| $20.3M | 0.19% |
+52,071
| New | +$24.1M |
|
168
Humana
HUM
$43.5B
| $20.1M | 0.19% |
+58,097
| New | +$22M |
|
169
Kymera Therapeutics
KYMR
$8.59B
| $20.1M | 0.19% |
500,930
+400,179
| +397% | +$14.3M |
|
170
Starbucks
SBUX
$120B
| $20M | 0.18% |
+218,410
| New | +$20.3M |
|
171
HP
HPQ
$26.4B
| $19.9M | 0.18% |
+658,571
| New | +$19.4M |
|
|
AZEK
172
DELISTED
The AZEK Co
AZEK
| $19.8M | 0.18% |
395,204
-75,174
| -16% | -$3.28M |
|
173
Dyne Therapeutics
DYN
$4.85B
| $19.8M | 0.18% |
697,927
+262,401
| +60% | +$5.93M |
|
174
Infosys
INFY
$51B
| $19.7M | 0.18% |
+1,096,573
| New | +$21.3M |
|
175
Huntington Ingalls Industries
HII
$12.7B
| $19.4M | 0.18% |
66,557
-77,497
| -54% | -$21.3M |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q1 2024 Portfolio in Review
As of Q1 2024, Woodline Partners held 678 positions worth $10.9B, up 18% from $9.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Woodline Partners deployed $806M of net new capital in Q1 2024, opening 211 new positions and adding to 171 existing holdings. Its largest new stake was Enerplus Corporation: 5,602,613 shares worth $110M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $110M trimmed.
- Woodline Partners's largest Q1 2024 buy was Enerplus Corporation: 5,602,613 shares worth $110M.
- Woodline Partners added most to TE Connectivity in Q1 2024, an estimated $81.6M increase.
- Woodline Partners's biggest Q1 2024 reduction was AbbVie, cutting an estimated $110M.
- Woodline Partners fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $113M.
- Woodline Partners's ten largest holdings make up 14% of its $10.9B portfolio in Q1 2024.
- Woodline Partners opened 211 new positions and closed 150 in Q1 2024.
- Woodline Partners's portfolio value rose 18% quarter-over-quarter to $10.9B.
Based on Woodline Partners's 13F filing for Q1 2024, filed 15 May 2024.